本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

23.22
+1.898.86%
成交量:82.10萬
成交額:1,855.04萬
市值:28.80億
市盈率:-183.04
高:23.30
開:21.90
低:21.88
收:21.33
52周最高:31.77
52周最低:11.86
股本:1.24億
流通股本:8,824.23萬
量比:1.59
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
淨資產收益率:-9.30%
總資產收益率:-1.95%
市淨率:15.20
市盈率(LYR):-183.04

資料載入中...

2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/25

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities